InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Abate Kristin, Directrice Comptable. Director active across 1 companies, notably Karyopharm Therapeutics Inc.. In total, 2 reports have been recorded. The latest transaction was disclosed on 13 May 2026 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
0121 shares0
Common Stock
SEC:0001193125-26-226616·
0121 shares0
Common Stock
SEC:0001193125-26-226616:0·
2 of 2 declarations
About Abate Kristin
Kristin Abate is the Chief Accounting Officer at Karyopharm Therapeutics Inc. She is responsible for managing accounting operations and preparing financial statements. Her role is essential for ensuring financial transparency and compliance with accounting standards.
